G Derosa, AFG Cicero, E Fogari… - … and metabolic research, 2011 - cat.inist.fr The aim of the study was to evaluate the effect of pioglitazone and glibenclamide on lipid profile and inflammatory parameters during an oral fat load (OFL). A total of 201 type 2 diabetic patients on treatment with metformin were enrolled in the study; pioglitazone was titrated till 45 mg/ ... All 2 versions
Q Wang, Y Cai, M Van de Casteele… - Journal of …, 2011 - Soc Endocrinology Sulfonylurea and metformin are used in the treatment of diabetes. Their chronic effects on β cells are not well known. We have shown that sustained exposure of rat β cells to glibenclamide increased their protein synthesis activity, while metformin caused an inhibition. The effect of ... Related articles - All 4 versions
N Katakami, H Kaneto, M Matsuhisa… - Diabetes Research and …, 2011 - Elsevier Glimepiride, a third-generation SU agent, has lesser insulin secretion action compared with conventional SUs such as glibenclamide. However, its hypoglycemic action is equivalent to them probably because it improves insulin sensitivity in subjects with and without diabetes [2], [3] and [4]. ... Related articles - All 3 versions
JW Stephens, TB Bodvarsdottir, K Wareham… - Diabetes Research and …, 2011 - Elsevier A randomized clinical trial was performed recruiting 27 subjects (HbA 1c between 7.5 and 10.5%) free from cardiovascular and renal disease. Glucose, insulin, C-peptide, glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), total antioxidant ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
